The general surgery devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. Medical devices that are used to perform bariatric surgery are referred to as bariatric surgery devices. GlobalData uses proprietary data and analytics to provide a comprehensive report on the gastric bands and balloons devices market, including market shares of different players within Italy. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the gastric bands and balloons market in Italy was Cousin Biotech followed by ReShape Lifesciences, Apollo Endosurgery, Bariatric Solutions, Allurion Technologies, Spatz FGIA, Laboratoire Endalis and Districlass Medical.
Bariatric surgery devices include gastric balloons, gastric bands and or adjustable gastric bands. A gastric balloon is an inflatable and expandable device that is implanted into the stomach. Gastric bands or adjustable gastric bands are inflatable silicone devices that are surgically implanted into the upper portion of the stomach to reduce the size of the stomach’s opening.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the gastric bands and balloons devices market within Italy was expected to be over $1m in 2021.
For the latest complete market share analysis of gastric bands and balloons device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
